TY - JOUR
T1 - The effectiveness of Tuina in managing chronic non-specific low back pain
T2 - A protocol of a multicenter international randomized controlled trial
AU - Zhou, Xuan
AU - Yang, Juan
AU - Ma, Qing Yu
AU - Guo, Yu
AU - He, Ke Jie
AU - Shen, Long Bin
AU - Fan, Qiao
AU - Philip, Cheong Kwok Chee
AU - Keng, Tay Boon
AU - Celia, Tan Ia Choo
AU - Bauer, Brent A.
AU - Chen, Jia Xu
N1 - Funding Information:
This project was supported by The HEAD Foundation (research@headfoundation.org), Singapore, and Huang Zhendong Research Fund for Traditional Chinese Medicine of Jinan University, China. The funders had no role in the design or conduct of the trial.
Publisher Copyright:
© 2022 Lippincott Williams and Wilkins. All rights reserved.
PY - 2022/2/18
Y1 - 2022/2/18
N2 - Background:Chronic non-specific low back pain (CNLBP) is a common complaint about medical care and carries a heavy social burden. The efficacy of Tuina (TN) or physiotherapy (PT) for CNLBP has been evaluated in previous systematic reviews. However, there is no high-quality evidence to support the efficacy of Tuina. Therefore, this study aims to conduct a large-scale, multicenter, high-quality clinical trial to provide evidence for Tuina to treat CNLBP.Methods:This is a multicenter, assessor-, and analyst-blinded, randomized controlled trial with 3 parallel arms: TN, PT, and TN combined with PT (Tuina combined with physiotherapy) group. Six hundred twelve eligible CNLBP patients will be randomly assigned to the groups in a 1:1:1 ratio in 3 centers. The TN intervention includes 9-step routine techniques, while the PT intervention includes a physiotherapy treatment plan based on a patient's symptoms. The interventions for both groups will last for 30 minutes and will be carried out for 6 sessions in 8 weeks. The primary outcome will be the visual analog scale pain score. And the secondary outcomes will include the Oswestry Disability Index, spinal range of motion, 36-item short-form health survey. Safety evaluation will be recorded during the whole study. All data in this randomized controlled trial will be analyzed by SAS 9.4.Discussion:The results of this trial will provide evidence to evaluate the efficacy of Tuina's value as a treatment for CNLBP.Trial registration:Chinese Clinical Trial Registry (ChiCTR2000040288, November 27, 2020).
AB - Background:Chronic non-specific low back pain (CNLBP) is a common complaint about medical care and carries a heavy social burden. The efficacy of Tuina (TN) or physiotherapy (PT) for CNLBP has been evaluated in previous systematic reviews. However, there is no high-quality evidence to support the efficacy of Tuina. Therefore, this study aims to conduct a large-scale, multicenter, high-quality clinical trial to provide evidence for Tuina to treat CNLBP.Methods:This is a multicenter, assessor-, and analyst-blinded, randomized controlled trial with 3 parallel arms: TN, PT, and TN combined with PT (Tuina combined with physiotherapy) group. Six hundred twelve eligible CNLBP patients will be randomly assigned to the groups in a 1:1:1 ratio in 3 centers. The TN intervention includes 9-step routine techniques, while the PT intervention includes a physiotherapy treatment plan based on a patient's symptoms. The interventions for both groups will last for 30 minutes and will be carried out for 6 sessions in 8 weeks. The primary outcome will be the visual analog scale pain score. And the secondary outcomes will include the Oswestry Disability Index, spinal range of motion, 36-item short-form health survey. Safety evaluation will be recorded during the whole study. All data in this randomized controlled trial will be analyzed by SAS 9.4.Discussion:The results of this trial will provide evidence to evaluate the efficacy of Tuina's value as a treatment for CNLBP.Trial registration:Chinese Clinical Trial Registry (ChiCTR2000040288, November 27, 2020).
KW - Tuina
KW - chronic non-specific low back pain
KW - clinical trials
KW - complementary medicine
KW - rehabilitation medicine
KW - traditional Chinese medicine
UR - http://www.scopus.com/inward/record.url?scp=85127371312&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85127371312&partnerID=8YFLogxK
U2 - 10.1097/MD.0000000000028883
DO - 10.1097/MD.0000000000028883
M3 - Article
C2 - 35363203
AN - SCOPUS:85127371312
SN - 0025-7974
VL - 101
SP - E28883
JO - Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries
JF - Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries
IS - 7
ER -